Cobalt Super Oral Solution 2.1mg/ml

País: Irlanda

Língua: inglês

Origem: HPRA (Health Products Regulatory Authority)

Ingredientes ativos:

Cobalt sulphate heptahydrate

Disponível em:

Chanelle Pharmaceuticals Manufacturing Limited

Código ATC:

QV06D

DCI (Denominação Comum Internacional):

Cobalt sulphate heptahydrate

Dosagem:

2.1 milligram(s)/millilitre

Forma farmacêutica:

Oral solution

Tipo de prescrição:

LR: Licensed Retailer as defined in national legislation

Grupo terapêutico:

Cattle, Sheep

Área terapêutica:

OTHER NUTRIENTS

Indicações terapêuticas:

Vitamins and minerals

Status de autorização:

Authorised

Data de autorização:

1989-10-01

Características técnicas

IRISH MEDICINES BOARD ACT 1995
EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007
(S.I. NO. 786 OF 2007)
VPA:
10987/032/001
Case No: 7005993
The Irish Medicines Board in exercise of the powers conferred on it by
Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby
grants to:
CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED
LOUGHREA
,
CO. GALWAY
,
IRELAND
an authorisation, subject to the provisions of the said Regulations
and the general conditions of the attached authorisation, in respect
of the
Veterinary Medicinal Product:
COBALT SUPER ORAL SOLUTION 2.1 MG/ML
The particulars of which are set out in Part 1 and Part 2 of the said
Schedule. The authorisation is also subject to any special conditions
as may
be specified in the said Schedule.
The authorisation, unless previously revoked, shall continue in force
from
01/10/2009
.
Signed on behalf of the Irish Medicines Board
________________
A person authorised in that behalf by the said Board.
(NOTE: From this date of effect, this authorisation replaces any
previous authorisation in respect of this product which is now null
and void.)
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_3_
_0_
_/_
_0_
_1_
_/_
_2_
_0_
_1_
_0_
_C_
_R_
_N_
_ _
_7_
_0_
_0_
_5_
_9_
_9_
_3_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Cobalt Super Oral Solution 2.1mg/ml
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Cobalt (as cobalt sulphate heptahydrate)